We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




FDA Bans Use of Powdered Gloves by Medical Professionals

By HospiMedica International staff writers
Posted on 05 Jan 2017
The U.S. More...
Food and Drug Administration (FDA; Silver Spring, MD, USA) have banned the use of powdered gloves by medical professionals, as they present an unreasonable and substantial risk of illness or injury.

The FDA’s final rule bans powdered surgeon's gloves, powdered patient examination gloves, and absorbable powder for lubricating a surgeon's glove. Because FDA classification regulations do not distinguish between powdered and non-powdered versions, the agency will amend the descriptions of these gloves to specify that the regulations for patient examination and surgeon's gloves will apply only to non-powdered gloves, while the powdered version of each type of glove will be added to the listing of banned devices in the regulations.

The FDA first identified powdered gloves as a potential risk to patients in 1997, determining at the time that airborne glove powder represents a threat to individuals allergic to natural rubber latex and could represent an important agent for sensitizing non-allergic individuals. At the time, however, the FDA refrained from issuing a full-scale ban, in part because they believed there were not enough adequate alternatives to powdered gloves in the marketplace.

In the intervening years, additional evidence has accumulated, suggesting the risks that come with using powdered gloves are far more wide-ranging. By the time the FDA actually proposed the ban, the agency was able to draw attention to reports that potential adverse effects included severe airway inflammation, wound inflammation, and post-surgical adhesions. In studying the likelihood of these side effects emerging, the FDA saw no significant differentiation between latex gloves and synthetic gloves.

“This ban is about protecting patients and healthcare professionals from a danger they might not even be aware of,” said Jeffrey Shuren, MD, director of FDA’s Center for Devices and Radiological Health (CDRH). “We take bans very seriously and only take this action when we feel it’s necessary to protect the public health.”

Health care personnel rely on medical gloves as barriers against transmission of infectious diseases and contaminants when conducting surgery, as well as when conducting more limited interactions with patients. Various types of powder have been used to lubricate gloves so that wearers could don the gloves more easily. However, the use of powder on medical gloves presents numerous risks to patients and health care workers, including inflammation, granulomas, and respiratory allergic reactions.

Related Links:
U.S. Food and Drug Administration


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Pressure Guidewire
SavvyWire
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new 3D heart mapping system visualizes all four chambers in real time (Photo courtesy of UPV)

Whole-Heart Mapping Technology Provides Comprehensive Real-Time View of Arrhythmias

Cardiac arrhythmias can be difficult to diagnose and treat because current mapping systems analyze the heart one chamber at a time. This fragmented view forces clinicians to infer electrical activity they... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.